146 related articles for article (PubMed ID: 29479942)
1. Recent perspectives of pediatric β-thalassemia.
An Q; Fan C; Xu S
Minerva Pediatr (Torino); 2022 Jun; 74(3):365-372. PubMed ID: 29479942
[TBL] [Abstract][Full Text] [Related]
2. Common fetal hemoglobin variants in Lebanese patients bearing the codon 29 beta gene mutation associated with different thalassemia phenotypes.
Brancaleoni V; Moukhadder HM; Consonni D; Koussa S; Di Pierro E; Cappellini MD; Taher A
Ann Hematol; 2019 Apr; 98(4):833-840. PubMed ID: 30506348
[TBL] [Abstract][Full Text] [Related]
3. Recent Progress in Gene Therapy and Other Targeted Therapeutic Approaches for Beta Thalassemia.
Hamed EM; Meabed MH; Aly UF; Hussein RRS
Curr Drug Targets; 2019; 20(16):1603-1623. PubMed ID: 31362654
[TBL] [Abstract][Full Text] [Related]
4. Beta-thalassemia.
Galanello R; Origa R
Orphanet J Rare Dis; 2010 May; 5():11. PubMed ID: 20492708
[TBL] [Abstract][Full Text] [Related]
5. Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches.
Sripichai O; Fucharoen S
Expert Rev Hematol; 2016 Dec; 9(12):1129-1137. PubMed ID: 27801605
[TBL] [Abstract][Full Text] [Related]
6. β-Thalassemia intermedia: a comprehensive overview and novel approaches.
Asadov C; Alimirzoeva Z; Mammadova T; Aliyeva G; Gafarova S; Mammadov J
Int J Hematol; 2018 Jul; 108(1):5-21. PubMed ID: 29380178
[TBL] [Abstract][Full Text] [Related]
7. A Genetic Variant Ameliorates β-Thalassemia Severity by Epigenetic-Mediated Elevation of Human Fetal Hemoglobin Expression.
Chen D; Zuo Y; Zhang X; Ye Y; Bao X; Huang H; Tepakhan W; Wang L; Ju J; Chen G; Zheng M; Liu D; Huang S; Zong L; Li C; Chen Y; Zheng C; Shi L; Zhao Q; Wu Q; Fucharoen S; Zhao C; Xu X
Am J Hum Genet; 2017 Jul; 101(1):130-138. PubMed ID: 28669403
[TBL] [Abstract][Full Text] [Related]
8. Beta-thalassemia.
Cao A; Galanello R
Genet Med; 2010 Feb; 12(2):61-76. PubMed ID: 20098328
[TBL] [Abstract][Full Text] [Related]
9. A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.
Zuccato C; Breda L; Salvatori F; Breveglieri G; Gardenghi S; Bianchi N; Brognara E; Lampronti I; Borgatti M; Rivella S; Gambari R
Ann Hematol; 2012 Aug; 91(8):1201-13. PubMed ID: 22460946
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
[TBL] [Abstract][Full Text] [Related]
11. Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia.
Breda L; Rivella S; Zuccato C; Gambari R
Expert Rev Hematol; 2013 Jun; 6(3):255-64. PubMed ID: 23782080
[TBL] [Abstract][Full Text] [Related]
12. Genetic Modifiers of Fetal Haemoglobin (HbF) and Phenotypic Severity in β-Thalassemia Patients.
Razak SAA; Murad NAA; Masra F; Chong DLS; Abdullah N; Jalil N; Alauddin H; Sabudin RZAR; Ithnin A; Khai LC; Aziz NA; Muda Z; Ibrahim H; Latiff ZA
Curr Mol Med; 2018; 18(5):295-305. PubMed ID: 30289070
[TBL] [Abstract][Full Text] [Related]
13. Alpha and beta thalassemia.
Muncie HL; Campbell J
Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyurea responsiveness in β-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity.
Pourfarzad F; von Lindern M; Azarkeivan A; Hou J; Kia SK; Esteghamat F; van Ijcken W; Philipsen S; Najmabadi H; Grosveld F
Haematologica; 2013 May; 98(5):696-704. PubMed ID: 23100274
[TBL] [Abstract][Full Text] [Related]
15. Association of Xmn1 -158 γG variant with severity and HbF levels in β-thalassemia major and sickle cell anaemia.
Dadheech S; Jain S; Madhulatha D; Sharma V; Joseph J; Jyothy A; Munshi A
Mol Biol Rep; 2014 May; 41(5):3331-7. PubMed ID: 24488321
[TBL] [Abstract][Full Text] [Related]
16. Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies.
Taher AT; Bou-Fakhredin R; Kattamis A; Viprakasit V; Cappellini MD
Expert Rev Hematol; 2021 Oct; 14(10):897-909. PubMed ID: 34493145
[TBL] [Abstract][Full Text] [Related]
17. Existence of HbF Enhancer Haplotypes at
Cyrus C; Vatte C; Borgio JF; Al-Rubaish A; Chathoth S; Nasserullah ZA; Jarrash SA; Sulaiman A; Qutub H; Alsaleem H; Alzahrani AJ; Steinberg MH; Ali AK
Biomed Res Int; 2017; 2017():1972429. PubMed ID: 28280727
[No Abstract] [Full Text] [Related]
18. Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia.
Bao X; Zhang X; Wang L; Wang Z; Huang J; Zhang Q; Ye Y; Liu Y; Chen D; Zuo Y; Liu Q; Xu P; Huang B; Fang J; Lao J; Feng X; Li Y; Kurita R; Nakamura Y; Yu W; Ju C; Huang C; Mohandas N; Li D; Zhao C; Xu X
Am J Hum Genet; 2021 Apr; 108(4):709-721. PubMed ID: 33735615
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of β-thalassemia: A narrative review.
Jaing TH; Chang TY; Chen SH; Lin CW; Wen YC; Chiu CC
Medicine (Baltimore); 2021 Nov; 100(45):e27522. PubMed ID: 34766559
[TBL] [Abstract][Full Text] [Related]
20. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease.
Khosravi MA; Abbasalipour M; Concordet JP; Berg JV; Zeinali S; Arashkia A; Azadmanesh K; Buch T; Karimipoor M
Eur J Pharmacol; 2019 Jul; 854():398-405. PubMed ID: 31039344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
